Light To Guide Our Feet
Light To Guide Our Feet

Menu

Collapse

Search Result

Collapse

Announcement

Collapse
No announcement yet.

What's Going On

Collapse

There are currently 57 users online. 1 members and 56 guests.

Most users ever online was 3,930 at 07:07 PM on 04-20-2019.

1 result in 0.0071 seconds.
Keywords
Members
Tags
EUAs x
  •  

  • FDA COVID-19 Update - - - FDA’s Ongoing Commitment to Transparency for COVID-19 EUAs

    U.S. Food and Drug Administration COVID-19 Update: FDA’s Ongoing Commitment to Transparency for COVID-19 EUAs | site |



    (November 17, 2020) - - Today the U.S. Food and Drug Administration (FDA) published the following information:

    November 17, 2020

    Statement From: Commissioner of Food and Drugs - Food and Drug Administration Stephen M. Hahn M.D. Emergency use authorizations, or EUAs, are an important tool in our country’s fight against COVID-19 and other public health emergencies. While EUAs have received increased attention during the COVID-19 public health emergency, EUAs are not a new tool to the FDA. I want to take a moment to reaffirm FDA’s commitment to transparency around the EUA process and share some updates on our plan to provide more information about FDA’s decisions to issue, revise or revoke EUAs for drugs and biological products, including vaccines. Earlier this year, we launched the COVID-19 Pandemic Recovery and
    ...
    See more | Go to post

Menu

Collapse

Trending

Collapse

  • Staff Reporter 1
    FDA COVID-19 Update - - - FDA’s Ongoing Commitment to Transparency for COVID-19 EUAs
    by Staff Reporter 1
    U.S. Food and Drug Administration COVID-19 Update: FDA’s Ongoing Commitment to Transparency for COVID-19 EUAs | site |



    (November 17, 2020) - - Today the U.S. Food and Drug Administration (FDA) published the following information:

    November 17, 2020

    Statement From: Commissioner of Food and Drugs - Food and Drug Administration Stephen M. Hahn M.D. Emergency use authorizations, or EUAs, are an important tool in our country’s fight against COVID-19 and other public health emergencies. While EUAs have received increased attention during the COVID-19 public health emergency, EUAs are not a new tool to the FDA. I want to take a moment to reaffirm FDA’s commitment to transparency around the EUA process and share some updates on our plan to provide more information about FDA’s decisions to issue, revise or revoke EUAs for drugs and biological products, including vaccines. Earlier this year, we launched the COVID-19 Pandemic Recovery and
    ...
    11-17-2020, 07:44 PM

Menu

Collapse

Menu

Collapse

Working...
X